Shopping Cart
- Remove All
- Your shopping cart is currently empty
PZL-A (PZL-A), an activator of mtDNA synthesis, restored the function and activity of the most common POLγ mutant variant and activated mtDNA synthesis in the cells of pediatric patients with fatal diseases, thereby enhancing the oxidative phosphorylation mechanism and the biogenesis of cellular respiration, and can be used to treat progressive diseases associated with mtDNA depletion.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $340 | In Stock | |
5 mg | $740 | In Stock | |
10 mg | $1,120 | In Stock | |
25 mg | $1,900 | In Stock | |
50 mg | $2,840 | In Stock | |
100 mg | $4,260 | In Stock |
Description | PZL-A (PZL-A), an activator of mtDNA synthesis, restored the function and activity of the most common POLγ mutant variant and activated mtDNA synthesis in the cells of pediatric patients with fatal diseases, thereby enhancing the oxidative phosphorylation mechanism and the biogenesis of cellular respiration, and can be used to treat progressive diseases associated with mtDNA depletion. |
In vitro | PZL-A (1 μM; 37 °C, 15–60 min) enhanced DNA polymerase activity of mutant POLγ complexes in primer extension assays using recombinant enzymes and M13 ssDNA. PZL-A improved processivity without affecting exonuclease function[1].PZL-A (≥10 nM; 4–7 d) promoted mtDNA recovery and improved mitochondrial function in POLG-mutant patient fibroblasts and neural stem cells after ethidium bromide–induced depletion[1]. |
Alias | PZLA, 1-[(4S)-8-Chlorochroman-4-yl)-3-(1-phenylpyrazol-3-yl)urea |
Molecular Weight | 368.82 |
Formula | C19H17ClN4O2 |
Cas No. | 3068830-89-4 |
Smiles | N(C(NC1=NN(C=C1)C2=CC=CC=C2)=O)[C@@H]3C=4C(OCC3)=C(Cl)C=CC4 |
Relative Density. | no data available |
Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.